agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.57B | 1.43B | 1.39B | 1.53B |
| Total Other Revenue | 1.91M | 2.51M | 2.88M | 2.94M | 2.90M |
| Total Revenue | 1.42B | 1.57B | 1.44B | 1.39B | 1.53B |
| Cost of Revenue | 1.36B | 1.66B | 1.50B | 1.45B | 1.48B |
| Gross Profit | 65.02M | -90.67M | -67.65M | -52.43M | 50.72M |
| SG&A Expenses | 48.12M | 58.76M | 52.11M | 56.16M | 65.43M |
| Depreciation & Amortization | 6.79M | 6.97M | 7.43M | 7.32M | 6.88M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.41B | 1.73B | 1.56B | 1.51B | 1.55B |
| Operating Income | 10.11M | -156.40M | -127.18M | -115.91M | -21.59M |
| Income Before Tax | 29.94M | -187.56M | -110.54M | -104.31M | -1.69M |
| Income Tax Expenses | 28.00K | 1.32M | -331.00K | 62.00K | 196.00K |
| Earnings from Continuing Operations | 29.92M | -188.88M | -110.21M | -104.37M | -1.89M |
| Earnings from Discontinued Operations | 19.00M | 0.00 | -- | -- | 14.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.92M | -188.88M | -110.21M | -104.37M | 12.11M |
| EBIT | 10.11M | -156.40M | -127.18M | -115.91M | -21.59M |
| EBITDA | 16.90M | -152.68M | -119.75M | -108.59M | -14.71M |
| EPS Basic | 2.95 | -11.39 | -6.65 | -6.31 | 0.73 |
| Normalized Basic EPS | 1.36 | -5.66 | -4.01 | -3.93 | -0.04 |
| EPS Diluted | 2.94 | -11.39 | -6.65 | -6.31 | 0.73 |
| Normalized Diluted EPS | 1.35 | -5.66 | -4.01 | -3.93 | -0.04 |
| Average Basic Shares Outstanding | 16.60M | 16.58M | 16.58M | 16.55M | 16.52M |
| Average Diluted Shares Outstanding | 16.66M | 16.58M | 16.58M | 16.55M | 16.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |